Yi‐Wei Tang
Impact in
- Infectious Diseases top 0.05%
- SARS-CoV-2 and COVID-19 Research
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing
Papers in
- Epidemiology 167
- Respiratory viral infections research 53
- Mycobacterium research and diagnosis 30
- Herpesvirus Infections and Treatments 23
-
- Viral gastroenteritis research and epidemiology 41
- Antimicrobial Resistance in Staphylococcus 32
- Clostridium difficile and Clostridium perfringens research 31
- Co-authors
- Charles W. Stratton (49 shared papers)Hongzhou Lu (7 shared papers)David H. Persing (18 shared papers)Haijing Li (64 shared papers)Michael J. Loeffelholz (4 shared papers)Jonathan E. Schmitz (3 shared papers)Barney S. Graham (12 shared papers)Melissa B. Miller (4 shared papers)
- Journals
- Journal of Clinical Microbiology (104 papers)Emerging Microbes & Infections (18 papers)Clinical Infectious Diseases (11 papers)Journal of Molecular Diagnostics (8 papers)Diagnostic Microbiology and Infectious Disease (7 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Yi‐Wei Tang
351 papers receiving 15.5k citations
Yi‐Wei Tang's Hit Papers
Peers
Comparison fields: 5 of 202
- Infectious Diseases 6.4k
- Clinical Biochemistry 1.4k
- Molecular Medicine 1.0k
- Epidemiology 4.8k
- Endocrinology 663
Countries citing papers authored by Yi‐Wei Tang
This map shows the geographic impact of Yi‐Wei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Wei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Wei Tang more than expected).
Fields of papers citing papers by Yi‐Wei Tang
This network shows the impact of papers produced by Yi‐Wei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Wei Tang. The network helps show where Yi‐Wei Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi‐Wei Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 367 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Hit paper breakdown → | 2020 | 2251 |
| 2 | Laboratory Diagnosis of COVID-19: Current Issues and Challenges Hit paper breakdown → | 2020 | 844 |
| 3 | Laboratory diagnosis of emerging human coronavirus infections – the state of the art Hit paper breakdown → | 2020 | 546 |
| 4 | Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era Hit paper breakdown → | 2015 | 434 |
| 5 | 1993 | 341 | |
| 6 | 2009 | 260 | |
| 7 | 2009 | 242 | |
| 8 | 2003 | 219 | |
| 9 | 1997 | 214 | |
| 10 | 1998 | 210 | |
| 11 | 2005 | 198 | |
| 12 | 2017 | 185 | |
| 13 | 2002 | 146 | |
| 14 | 2019 | 141 | |
| 15 | 2010 | 134 | |
| 16 | 2009 | 133 | |
| 17 | 2007 | 133 | |
| 18 | 2003 | 125 | |
| 19 | 1994 | 121 | |
| 20 | 2016 | 116 |
About Yi‐Wei Tang
Yi‐Wei Tang is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Clinical Biochemistry and Molecular Medicine, having authored 367 papers that have together received 16.0k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (56 papers), Respiratory viral infections research (53 papers), Viral gastroenteritis research and epidemiology (41 papers), Antibiotic Resistance in Bacteria (34 papers), Antimicrobial Resistance in Staphylococcus (32 papers), Clostridium difficile and Clostridium perfringens research (31 papers), Mycobacterium research and diagnosis (30 papers) and Herpesvirus Infections and Treatments (23 papers). The work is most often cited by research in Infectious Diseases (6.4k citations), Clinical Biochemistry (1.4k citations), Molecular Medicine (1.0k citations), Epidemiology (4.8k citations) and Endocrinology (663 citations). Yi‐Wei Tang has collaborated with scholars based in United States, China and France. Frequent co-authors include Charles W. Stratton, Hongzhou Lu, David H. Persing, Haijing Li, Michael J. Loeffelholz, Jonathan E. Schmitz, Barney S. Graham, Melissa B. Miller, N. Esther Babady and Gary W. Procop. Their work appears in journals such as Journal of Clinical Microbiology, Emerging Microbes & Infections, Clinical Infectious Diseases, Journal of Molecular Diagnostics and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.